Simplify Asset Management Inc. Has $1.45 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Simplify Asset Management Inc. boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 78.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,793 shares of the medical device company’s stock after buying an additional 6,925 shares during the period. Simplify Asset Management Inc.’s holdings in Cooper Companies were worth $1,452,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of COO. Byrne Asset Management LLC acquired a new stake in Cooper Companies in the fourth quarter valued at about $33,000. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $34,000. Brown Brothers Harriman & Co. boosted its stake in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after purchasing an additional 275 shares in the last quarter. West Financial Advisors LLC bought a new stake in shares of Cooper Companies during the 4th quarter valued at approximately $49,000. Finally, Atala Financial Inc acquired a new position in Cooper Companies during the 4th quarter worth approximately $51,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $81.71 on Friday. The company has a market capitalization of $16.34 billion, a PE ratio of 41.90, a P/E/G ratio of 2.25 and a beta of 1.02. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a twelve month low of $77.05 and a twelve month high of $112.38. The firm has a fifty day simple moving average of $90.05 and a 200 day simple moving average of $98.09.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Wells Fargo & Company boosted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley reduced their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Piper Sandler reiterated an “overweight” rating and issued a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Robert W. Baird reduced their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Finally, BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.